Cytomegalovirus Infections
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation [Phase 3]
Phase 3 study assessing valganciclovir for CMV prophylaxis after renal transplantation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection [Phase 1, Phase 2]
Preliminary clinical trial update on low-dose IL-2 and ganciclovir for cytomegalovirus infections (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus [NA]
Clinical trial completion update for a study on transmission of cytomegalovirus infection from mother to fetus; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Cytomegalovirus Infection in Patients With HIV-1 Infection [Phase 3]
Phase 3 clinical trial update for cytomegalovirus infection in patients with HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine [NA]
A completed clinical trial update evaluating the long-term persistence of GSK's cytomegalovirus vaccine candidate, with results posted in 20…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females [Phase 2]
A Phase 2 trial evaluating the gB/MF59 vaccine to prevent cytomegalovirus infection in healthy adolescent females has completed.
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Role of Endothelial Biomarkers in Patients With Coronary Artery Disease
Clinical trial update exploring endothelial biomarkers in patients with coronary artery disease (including those with diabetes mellitus); th…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients [Phase 2]
A Phase 2 study evaluating MCMV5322A/MCMV3068A for the prevention of Cytomegalovirus disease in high-risk kidney transplant recipients has c…
-
CLINICAL_TRIALS research · 2016-12-26Clinical Trial Update: The Influence of Chronic CMV Infection on Influenza Vaccine Responses [Phase 4]
A Phase 4 clinical trial examining how chronic CMV infection affects responses to the influenza vaccine, completed with posted results.
-
FDA approval · 2016-11-10FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)
The FDA approved a supplemental application for FOSCAVIR (foscarnet sodium) submitted by Clinigen Limited.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients [Phase 4]
A Phase 4 trial (VICTOR study) comparing oral valganciclovir (Valcyte) with intravenous ganciclovir in CMV disease among solid organ transpl…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Cytomegalovirus (CMV) Infection in Amniotic Fluid
Clinical trial update reporting a completed study on cytomegalovirus infection in amniotic fluid. Sponsored by the University of Pennsylvani…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Viral Activation Transfusion Study (VATS) [NA]
The Viral Activation Transfusion Study (VATS) sponsored by NHLBI has completed, investigating AIDS/HIV-related infections and cytomegaloviru…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients [Phase 4]
Phase 4 study evaluated valganciclovir dosing in pediatric solid organ transplant recipients to prevent CMV infection; results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Cytomegalovirus Spread and Reactivation in Blood Cells
A National Heart, Lung, and Blood Institute–funded clinical trial investigating cytomegalovirus spread and reactivation in blood cells has c…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
NHLBI-sponsored pediatric study on pulmonary and cardiovascular complications of vertically transmitted HIV infection has completed.
-
FDA approval · 2016-03-31FDA Approved: VALGANCICLOVIR HYDROCHLORIDE — Original Application (NorthStar Rx LLC)
FDA approved an original application for valganciclovir hydrochloride (generic) to be marketed by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients [Phase 4]
A Phase 4 clinical trial evaluated using low-dose sirolimus with tacrolimus in elderly kidney transplant patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients
An observational study evaluating valganciclovir (Valcyte) for cytomegalovirus infections in D+/R- liver transplant recipients completed, wi…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. [Phase 1]
Phase 1 relative bioavailability study of Valcyte (valganciclovir) in lung transplant recipients with or without cystic fibrosis; results ha…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients [Phase 3]
Phase 3 trial comparing maribavir to oral ganciclovir for CMV disease prevention in liver transplant recipients has completed with results p…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients [Phase 3]
Phase 3 trial evaluating prophylactic maribavir to prevent CMV disease in stem cell transplant recipients has completed with results posted.
-
CLINICAL_TRIALS research · 2015-06-03Clinical Trial Update: Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus [NA]
A completed clinical trial evaluating behavioral modification to prevent congenital cytomegalovirus infection during pregnancy.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Evaluation of the Artus® CMV PCR Test
This update reports on a completed clinical trial evaluating the Artus CMV PCR Test for cytomegalovirus infections, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody [Phase 1]
A Phase 1 safety study of a human anti-Cytomegalovirus monoclonal antibody sponsored by Theraclone Sciences has completed.